342 related articles for article (PubMed ID: 7690421)
1. In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor.
Jeang KT; Chun R; Lin NH; Gatignol A; Glabe CG; Fan H
J Virol; 1993 Oct; 67(10):6224-33. PubMed ID: 7690421
[TBL] [Abstract][Full Text] [Related]
2. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
[TBL] [Abstract][Full Text] [Related]
3. Second-site long terminal repeat (LTR) revertants of replication-defective human immunodeficiency virus: effects of revertant TATA box motifs on virus infectivity, LTR-directed expression, in vitro RNA synthesis, and binding of basal transcription factors TFIID and TFIIA.
Kashanchi F; Shibata R; Ross EK; Brady JN; Martin MA
J Virol; 1994 May; 68(5):3298-307. PubMed ID: 8151790
[TBL] [Abstract][Full Text] [Related]
4. Human immunodeficiency virus type 1 Tat prevents dephosphorylation of Sp1 by TCF-4 in astrocytes.
Rossi A; Mukerjee R; Ferrante P; Khalili K; Amini S; Sawaya BE
J Gen Virol; 2006 Jun; 87(Pt 6):1613-1623. PubMed ID: 16690926
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
[TBL] [Abstract][Full Text] [Related]
6. Sp1 transcription factor is required for in vitro basal and Tat-activated transcription from the human immunodeficiency virus type 1 long terminal repeat.
Suñé C; García-Blanco MA
J Virol; 1995 Oct; 69(10):6572-6. PubMed ID: 7666561
[TBL] [Abstract][Full Text] [Related]
7. Transcription of the human immunodeficiency virus type 1 (HIV-1) promoter in central nervous system cells: effect of YB-1 on expression of the HIV-1 long terminal repeat.
Sawaya BE; Khalili K; Amini S
J Gen Virol; 1998 Feb; 79 ( Pt 2)():239-46. PubMed ID: 9472608
[TBL] [Abstract][Full Text] [Related]
8. A cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activation.
Perkins ND; Edwards NL; Duckett CS; Agranoff AB; Schmid RM; Nabel GJ
EMBO J; 1993 Sep; 12(9):3551-8. PubMed ID: 8253080
[TBL] [Abstract][Full Text] [Related]
9. Different members of the Sp1 multigene family exert opposite transcriptional regulation of the long terminal repeat of HIV-1.
Majello B; De Luca P; Hagen G; Suske G; Lania L
Nucleic Acids Res; 1994 Nov; 22(23):4914-21. PubMed ID: 7800480
[TBL] [Abstract][Full Text] [Related]
10. The hepatitis B virus X protein induces HIV-1 replication and transcription in synergy with T-cell activation signals: functional roles of NF-kappaB/NF-AT and SP1-binding sites in the HIV-1 long terminal repeat promoter.
Gómez-Gonzalo M; Carretero M; Rullas J; Lara-Pezzi E; Aramburu J; Berkhout B; Alcamí J; López-Cabrera M
J Biol Chem; 2001 Sep; 276(38):35435-43. PubMed ID: 11457829
[TBL] [Abstract][Full Text] [Related]
11. Role of SP1-binding domains in in vivo transcriptional regulation of the human immunodeficiency virus type 1 long terminal repeat.
Harrich D; Garcia J; Wu F; Mitsuyasu R; Gonazalez J; Gaynor R
J Virol; 1989 Jun; 63(6):2585-91. PubMed ID: 2657100
[TBL] [Abstract][Full Text] [Related]
12. Human immunodeficiency viruses containing heterologous enhancer/promoters are replication competent and exhibit different lymphocyte tropisms.
Chang LJ; McNulty E; Martin M
J Virol; 1993 Feb; 67(2):743-52. PubMed ID: 8419644
[TBL] [Abstract][Full Text] [Related]
13. Artificial zinc finger fusions targeting Sp1-binding sites and the trans-activator-responsive element potently repress transcription and replication of HIV-1.
Kim YS; Kim JM; Jung DL; Kang JE; Lee S; Kim JS; Seol W; Shin HC; Kwon HS; Van Lint C; Hernandez N; Hur MW
J Biol Chem; 2005 Jun; 280(22):21545-52. PubMed ID: 15743774
[TBL] [Abstract][Full Text] [Related]
14. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells.
Chang LJ; Zhang C
Virology; 1995 Aug; 211(1):157-69. PubMed ID: 7645208
[TBL] [Abstract][Full Text] [Related]
15. Modulation of Sp1 phosphorylation by human immunodeficiency virus type 1 Tat.
Chun RF; Semmes OJ; Neuveut C; Jeang KT
J Virol; 1998 Apr; 72(4):2615-29. PubMed ID: 9525578
[TBL] [Abstract][Full Text] [Related]
16. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J
J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193
[TBL] [Abstract][Full Text] [Related]
17. Interactions of thyroid hormone receptor with the human immunodeficiency virus type 1 (HIV-1) long terminal repeat and the HIV-1 Tat transactivator.
Desai-Yajnik V; Hadzic E; Modlinger P; Malhotra S; Gechlik G; Samuels HH
J Virol; 1995 Aug; 69(8):5103-12. PubMed ID: 7609079
[TBL] [Abstract][Full Text] [Related]
18. Functional similarities between HIV-1 Tat and DNA sequence-specific transcriptional activators.
Madore SJ; Cullen BR
Virology; 1995 Feb; 206(2):1150-4. PubMed ID: 7856090
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of nuclear factor-kappa B acetylation by coactivator p300 and HIV-1 Tat proteins.
Furia B; Deng L; Wu K; Baylor S; Kehn K; Li H; Donnelly R; Coleman T; Kashanchi F
J Biol Chem; 2002 Feb; 277(7):4973-80. PubMed ID: 11739381
[TBL] [Abstract][Full Text] [Related]
20. Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat.
Berkhout B; Jeang KT
J Virol; 1992 Jan; 66(1):139-49. PubMed ID: 1727476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
